Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, May 14, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, today announced that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at multiple conferences in May.
Help employers find you! Check out all the jobs and post your resume.
